Literature DB >> 32216063

Homonymous quadrantanopia associated with hyperosmolar hyperglycemic syndrome.

Chika Mizuguchi1, Yuka Sato2, Hiroki Imai1, Masaki Kakizawa3, Koh Yamashita2, Toru Aizawa2.   

Abstract

We encountered a 64-year-old man with hyperosmolar hyperglycemic syndrome, having a sudden-onset homonymous right inferior quadrantanopia. This is the first documentation of such a phenomenon in hyperosmolar hyperglycemic syndrome. We believe this is a variant of hemianopia in patients with hyperglycemic hyperosmolar syndrome.
© 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Entities:  

Year:  2020        PMID: 32216063      PMCID: PMC7477511          DOI: 10.1111/jdi.13242

Source DB:  PubMed          Journal:  J Diabetes Investig        ISSN: 2040-1116            Impact factor:   4.232


Hemianopia occurs as a rare complication of diabetic hyperglycemic hyperosmolar syndrome (HHS; Table S1) , , , , but quadrantanopia has not been reported as a complication of diabetes. A man aged in his 60s presented to us with a 3‐day history of reddish and greenish hallucinations with impaired focusing. He had also experienced a mild frontal headache for a few days. He was diagnosed as having diabetes approximately 10 years earlier with glycosylated hemoglobin >10% (86 mmol/mol). He reported receiving a non‐pharmacological treatment, and his glycosylated hemoglobin level lowered to approximately 6.0% (42 mmol/mol) according to him. However, he had left the diabetes untreated in the recent 5 years. On presentation, he was fully alert and complained of excessive thirst. He was obese (the body mass index 27.9 kg/m2), and a physical examination revealed dry mouth; his blood pressure was 138/82 mmHg and physical findings were otherwise not contributory. His random sample plasma glucose was 32.0 mmol/L, glycosylated hemoglobin 14.8% (138 mmol/mol), osmolality 302 mOsm/kg (reference range 276–292 mOsm/kg), urinary sugar was 3+, ketone bodies negative and plasma 3‐hydroxybutyrate 75 μmol/L (reference range <85 μmol/L). The patient was fully alert and had no involuntary movements, such as choreoathetosis, ballismus, dysphagia and seizures, so we did not carry out electroencephalography. Ophthalmological examination showed discrete homonymous right inferior quadrantanopia (Figure 1, upper panel) and mild non‐proliferative diabetic retinopathy. The anopia mostly dissipated by day 8 (Figure 1, lower panel), with lowering of plasma glucose during this period to 10.7 ± 2.5 mmol/L (mean ± standard deviation of 32 blood samples, of which 21 were preprandial samples and 11 postprandial samples) by fluid and insulin. Magnetic resonance imaging (MRI) of the brain taken on day 1 and 8 showed no abnormality (Figure S1). The patient returned to normal daily life on day 10, and there have been no visual symptoms after the discharge, during 6 months of follow up.
Figure 1

Homonymous right inferior quadrantanopia on admission (upper panel), which mostly dissipated by day 8 (lower panel).

Homonymous right inferior quadrantanopia on admission (upper panel), which mostly dissipated by day 8 (lower panel). This is the first documentation of quadrantanopia associated with HHS. The quadrantanopia had a rapid onset and was short‐lasting, and well synchronized with the temporal profile of glycemia in this patient. Sharply demarcated inferior quadrantanopia seen in the present patient suggested the localization of the responsible neuronal lesion in the occipital lobe. However, the brain MRI was normal throughout the course of the current episode. Vascular events and brain tumors might be listed as differential diagnosis, but normal MRI easily excluded such possibilities. There have been case reports in which HHS‐associated hemianopia without MRI abnormality was documented1, 2, 3, 4. The mechanisms of cerebral injury in quadrantanopia associated with hyperglycemia are unclear. For hemianopia, it was postulated to include intracellular dehydration, reactive oxygen species generation and others by Strowd et al 4. Some of them might have been responsible for the quadrantanopia seen in the present patient. Whatever the abnormality was, the rapid recovery and negative MRI suggested that the lesion might have been small in size and/or the degree of plasticity rather high. Diagnosis of HHS at a relatively mild stage followed by rapid normalization of glucose might have contributed to the benign clinical course of this patient as well. In conclusion, one should keep in mind that hemianopia and quadrantanopia can take place as neuro‐ophthalmological complications of HHS.

Disclosure

The authors declare no conflict of interest. Figure S1 | Brain magnetic resonance imaging (T2‐weighted image). There are no abnormalities, such as occipital subcortical hypointensity, in these images. No abnormality was observed in the optic tract as well (not shown). Click here for additional data file. Table S1 | Previous cases of hemianopia associated with hyperglycemia. Click here for additional data file.
  4 in total

1.  Metabolic disorders presenting as stroke.

Authors:  S F Berkovic; P F Bladin; D G Darby
Journal:  Med J Aust       Date:  1984-03-31       Impact factor: 7.738

2.  Clinical reasoning: acute-onset homonymous hemianopia with hyperglycemia: seeing is believing.

Authors:  Roy E Strowd; Ashley Wabnitz; Nikhil Balakrishnan; Jeffrey Craig; Charles H Tegeler
Journal:  Neurology       Date:  2014-04-15       Impact factor: 9.910

3.  Homonymous hemianopia in nonketotic hyperglycemia is an ictal phenomenon.

Authors:  Aaron Stayman; Bassel W Abou-Khalil; Patrick Lavin; Nabil J Azar
Journal:  Neurol Clin Pract       Date:  2013-10

4.  Visual hallucination of coloured numbers secondary to hyperglycaemia.

Authors:  Phillip Fletcher; Anthony Pereira
Journal:  BMJ Case Rep       Date:  2011-02-09
  4 in total
  1 in total

1.  Left Homonymous Hemianopia: An Uncommon, Neuro-ophthalmological Presentation of Hyperglycemic Hyperosmolar State.

Authors:  Daniel Kashani; Ganesh K Thirunavukkarasu; Saeed Javidi; Leonel Mendoza; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2020-09-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.